Antibody Neutralizes SARS and COVID-19 Coronaviruses – On Accelerated Path Toward Clinical Trials
The coronavirus neutralizing antibody, called S309, is on an accelerated path toward clinical trials. An antibody first identified in a blood sample from a patient…